Paxalisib in DIPG, Phase I, has finally been set to ”completed“ at Clintrials with 4th September 2022 as the actual study completion date:
https://clinicaltrials.gov/ct2/show/NCT03696355
I am hoping results will be published soon.
Add to My Watchlist
What is My Watchlist?